Skip to the page

Data / Form D filings / iTherx Pharma, Inc.

iTherx Pharma, Inc.: Form D filing

iTherx Pharma, Inc., a pharmaceuticals company in San Diego, CA, filed a Form D with the SEC in 2011. The latest, on November 4, 2011, reports $3.2 million sold of a $3.2 million offering to 19 investors.

Find out what iTherx Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
14090 CAMINITO VISTANA, San Diego, CA, 92130
Phone
(858) 824-1100
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2011
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1531965

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 4, 2011New notice$3,173,595$3,173,595$019Sep 8, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven B. Gerber, M.D.Director
John H. FriedmanExecutive Officer, Director
Franklin H. BergerDirector
Eve H. SlaterDirector
Amanda H. IlesExecutive Officer
Flossie F. Wong-Staal, Ph.D.Executive Officer, Director
Jeffrey F. McKelvy, Ph.D.Executive Officer, Director
Frank F. Litvack, M.D.Director

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Oct 31, 2011 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what iTherx Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.